ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Food Microbiology
This article is part of the Research TopicProbiotic Potential: Lactic Acid Bacteria in Advancing Functional Foods and Health OutcomesView all 5 articles
Camel milk and fermented camel milk prevent dextran sulfate sodium-induced ulcerative colitis via the intestinal flora-short-chain fatty acids-mucosal barrier axis in mice
Provisionally accepted- 1Inner Mongolia Agricultural University, Hohhot, China
- 2Inner Mongolia Saikexing Institute of Breeding and Reproductive Biotechnology in Domestic Animal Co Ltd, Hohhot, China
- 3Kalaqin Banner Wangyefu Town Sishijiazi Health Center, Chifeng City, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Ulcerative colitis poses a significant threat to human health. Dysbiosis of the gut microbiota and decreased levels of short-chain fatty acids are known contributors to the pathogenesis of ulcerative colitis. While camel milk and fermented camel milk have demonstrated beneficial effects in alleviating intestinal inflammation, the differences in their preventive efficacy against ulcerative colitis and the underlying mechanisms remain unclear. Dextran sulfate sodium can induce ulcerative colitis, at least in part, through activation of the NF-κB/MAPK signaling pathway. This study aims to investigate the differential preventive effects of camel milk and fermented camel milk against dextran sulfate sodium -induced ulcerative colitis in mice and to elucidate the underlying mechanisms mediated by the gut microbiota and short-chain fatty acids. Through the study, we found that preemptive intervention with camel milk and fermented camel milk significantly mitigated dextran sulfate sodium -triggered pathological manifestations, including body weight loss (e.g., from 97% in DSS group to 99% in FTC group, p<0.01), elevated Disease Activity Index (from a peak score of 2.8 to 2.0, p<0.01), colonic shortening (from 5.8 cm to 6.2 cm, p<0.01). Both treatments also restored intestinal barrier integrity, increasing the expression of tight junction proteins, and elevated the anti-inflammatory cytokine IL-10 (p<0.05). Then, it can also regulate the intestinal flora imbalance in mice with ulcerative colitis. Finally, we found that both can also reduce the reduction of short-chain fatty acids in mice with ulcerative colitis (p<0.05). Notably, the fermented camel milk exhibited superior efficacy compared to the camel milk in mitigating fermented camel milk -induced body weight loss, the decline of IL-10 and E-cadherin levels, microbial diversity decreasing, the Bacteroidetes/Firmicutes ratio increasing, and the relative abundance of Lachnospiraceae NK4A136 group decreasing in ulcerative colitis mice. Our findings demonstrate that preemptive intake of camel milk and fermented camel milk effectively prevents ulcerative colitis by preserving the intestinal barrier, regulating immune responses, and restoring gut microbiota homeostasis and short chain fatty acids production, with fermented camel milk offering enhanced benefits. We hold optimistic prospects for camel milk and fermented camel milk as dietary supplements to prevent ulcerative colitis and stabilize gut microbiota homeostasis.
Keywords: Fermented camel milk, Gut Microbiota, intestinal barrier function, mouse model, Preemptive intervention, SCFAs, ulcerative colitis
Received: 13 Oct 2025; Accepted: 03 Dec 2025.
Copyright: © 2025 Xu, Dong, Guo, Li, Abbas, Li, Zhang and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Guofen Zhao
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
